<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01000701</url>
  </required_header>
  <id_info>
    <org_study_id>SPUM-ACS</org_study_id>
    <nct_id>NCT01000701</nct_id>
  </id_info>
  <brief_title>Inflammation and Acute Coronary Syndromes</brief_title>
  <acronym>SPUM-ACS</acronym>
  <official_title>Inflammation and Acute Coronary Syndromes (ACS) - Novel Strategies for Prevention and Clinical Management</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Bern</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Geneva</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Lausanne Hospitals</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Subproject 1: Optimize prevention after acute coronary syndromes (ACS) by improving caregiver
      and patient education (http://elips.hug-ge.ch/eng/index_eng2.htm)

      Subproject 2: Discover novel genomic biomarkers of ACS in leukocyte subsets by means of
      analyzing gene expression profiles and function

      Subproject 3: Evaluate novel diagnostic and prognostic biomarkers in soluble form in
      blood/plasma and urine

      Subproject 5: Visualize the vulnerable plaque using intravascular ultrasound/optical
      coherence tomography (IVUS/OCT) and correlate with outcome and biomarkers

      Subproject 7: Characterize the effects of inflammation on progenitor/stem cell-mediated
      repair after ACS by means of analyzing gene expression profiles and function
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Major adverse cardiovascular events (MACE) in overall population, defined as composite of cardiac death, myocardial infarction or ischemia-driven revascularization</measure>
    <time_frame>30 days and 12 months follow-up</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>SP2/SP3/SP5: temporal change in biomarkers (12 months).</measure>
    <time_frame>SP2/SP3/SP5: 13 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation with plaque burden and neointimal thickness assessed by IVUS/OCT imaging in ST segment elevation myocardial infarction (STEMI) subgroup (13 months)</measure>
    <time_frame>13 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">4000</enrollment>
  <condition>Acute Coronary Syndromes</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood, Thrombus, blood cells, urine
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients presenting with Acute Coronary Syndromes

        3 control groups:

          -  patients with stable coronary artery disease

          -  healthy controls (blood bank)

          -  peripheral artery occlusive disease (CLI/ALI)
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients with age ≥ 18 years presenting within 5 days (preferably within 72 hours)
             after pain onset with the main diagnosis of ACS (acute myocardial infarction: STEMI
             /NSTEMI and threatened infarction: unstable angina pectoris), who enter the hospital:
             The patients show symptoms, which are compatible with angina pectoris (chest pain,
             dyspnoea) and at least one of the following characteristics:

               -  persistent ST-segment elevation or depression, T inversion or dynamic ECG
                  changes, new left bundle branch block (LBBB)

               -  Evidence of positive troponin by local laboratory reference values with a rise
                  and/or fall in serial troponin levels

               -  known coronary artery disease, specified as status after myocardial infarction,
                  CABG, or PCI or newly documented ≥50% stenosis of an epicardial coronary artery
                  during the initial catheterization

        Exclusion Criteria:

          -  Severe physical disability,

          -  Dementia (inability to comprehend study), OR

          -  Less than 1 year of life expectancy (for non-cardiac reasons).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Thomas F Luscher, MD</last_name>
    <phone>0041 44 255</phone>
    <phone_ext>2121</phone_ext>
    <email>cardiotfl@gmx.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christian M Matter, MD</last_name>
    <phone>0041 44 635</phone>
    <phone_ext>6467</phone_ext>
    <email>christian.matter@uzh.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital, Bern</name>
      <address>
        <city>Bern</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephan Windecker, MD</last_name>
      <email>stephan.windecker@insel.ch</email>
    </contact>
    <investigator>
      <last_name>Stephan Windecker, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lorenz Raeber, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Peter Jueni, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Giulio G Stefanini</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital, Geneva</name>
      <address>
        <city>Geneva</city>
        <zip>1211</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>François Mach, MD</last_name>
      <email>francois.mach@hcuge.ch</email>
    </contact>
    <contact_backup>
      <last_name>Pierre-Frederic Keller, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Francois Mach, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre-Frederic Keller, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sebastian Carballo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Carballo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas Perneger, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marco Roffi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Baris Gencer, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital, Lausanne</name>
      <address>
        <city>Lausanne</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolas Rodondi, MD</last_name>
      <email>nicolas.rodondi@insel.ch</email>
    </contact>
    <investigator>
      <last_name>Nicolas Rodondi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Reto Auer, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Nanchen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital, Zurich</name>
      <address>
        <city>Zurich</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas F Luscher, MD</last_name>
      <email>cardiotfl@gmx.ch</email>
    </contact>
    <investigator>
      <last_name>Christian M Matter, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Roland Klingenberg, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ulf Landmesser, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christian Templin, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Willibald Maier, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lukas Altwegg, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas F Luscher, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 22, 2009</study_first_submitted>
  <study_first_submitted_qc>October 22, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 23, 2009</study_first_posted>
  <last_update_submitted>September 8, 2016</last_update_submitted>
  <last_update_submitted_qc>September 8, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 9, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Inflammation</keyword>
  <keyword>ACS</keyword>
  <keyword>Prevention</keyword>
  <keyword>Education</keyword>
  <keyword>Clinical management</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Acute Coronary Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

